Psychedelics, spirituality, and existential distress in patients at the end of life.
Where this comes from
- Record sourced from PubMed, PMID 40169224.
- Also identified by DOI 10.3949/ccjm.92a.24100.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Psychedelic-assisted therapy clinical trials conducted over the past decade have prompted increased interest in the use of psychedelics to treat nonphysical suffering, which can include significant spiritual and existential distress at the end of life. The authors explore the role of psychedelics in helping to address patients' spiritual and existential suffering from a medical, ethical, and legal perspective, with the aim of stimulating discussion and research on this timely and clinically promising topic.
Medical subject headings
- Spirituality
- Hallucinogens
- Terminal Care
- Stress, Psychological